首页> 美国卫生研究院文献>Psychiatry Investigation >Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized 8 Week Multicenter Open-Label Clinical Trial

【2h】

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized 8 Week Multicenter Open-Label Clinical Trial

机译：Buspirone在患有和没有非典型特征的主要抑郁障碍患者中综合血酮增强的疗效：随机8周多中心开放标签临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study investigated the treatment response and cognitive enhancement effects of buspirone augmentation of escitalopram in patients with major depressive disorder (MDD), according to atypical feature subtypes of MDD.

机译：本研究根据MDD的非典型特征亚型，调查了在主要抑郁症（MDD）患者中EssitalProne的治疗反应和认知增强效应。

著录项

期刊名称 Psychiatry Investigation
作者
Cheolmin Shin; Young-Hoon Ko; Se-Hoon Shim; Ji Sun Kim; Kyoung-Sae Na; Sang-Woo Hahn; Seung-Hwan Lee;
展开▼
作者单位

展开▼
年(卷),期 2020(17),8
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类精神病学;
关键词
Atypical features; Major depressive disorder; Digit span; Buspirone; Escitalopram;

相似文献

外文文献
中文文献

1. Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial [J] . Cheolmin Shin, Young-Hoon Ko, Se-Hoon Shim, Psychiatry Investigation . 2020,第8期

机译：Buspirone在患有和没有非典型特征的主要抑郁障碍患者中综合血酮增强的疗效：随机，8周，多中心，开放标签临床试验
2. Efficacy and safety of generic escitalopram (Lexacure?) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study [J] . Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Neuropsychiatric Disease and Treatment . 2015,第4期

机译：通用依他普仑（Lexacure？）在重度抑郁症患者中的疗效和安全性：一项为期6周的多中心，随机，盲定，依他普仑比较，非劣效性研究
3. PS89. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study [J] . The international journal of neuropsychopharmacology . 2016,第Suppla1期

机译：PS89。焦虑症状对重度抑郁症患者神经认知功能改善的影响：一项为期12周的多肽田奈汀与依他普仑随机试验，CAMPION研究
4. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
5. An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features [O] . Chi-Un Pae, Prakash S. Masand, Kathleen Peindl, 2019

机译：艾司西酞普兰对具有典型特征的重度抑郁症患者的开放标签，评分者盲目的，灵活剂量的8周试验
6. An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features [O] . Pae, Chi-Un, Masand, Prakash S., Peindl, Kathleen, 2008

机译：依西酞普兰的开放标签，评分者盲目的，柔性剂量，8周试验对具有典型特征的重度抑郁症患者

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized 8 Week Multicenter Open-Label Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅